Sari Fishman
Corporate Officer/Principal at CAN-FITE BIOPHARMA LTD.
Net worth: - $ as of 2024-04-29
Sari Fishman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 2013-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2003-12-31 | 2013-12-31 |
Career history of Sari Fishman
Former positions of Sari Fishman
| Companies | Position | Start | End |
|---|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Tech/Sci/R&D Officer | - | - |
Training of Sari Fishman
| Bar-Ilan University | Doctorate Degree |
Statistics
International
| Israel | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Private companies | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Stock Market
- Insiders
- Sari Fishman
- Experience
